Document Detail

Sera from preeclampsia patients elicit symptoms of human disease in mice and provide a basis for an in vitro predictive assay.
MedLine Citation:
PMID:  20889559     Owner:  NLM     Status:  MEDLINE    
Early diagnosis and treatment of preeclampsia would significantly reduce maternal and fetal morbidity and mortality. However, its etiology and prediction have remained elusive. Based on the hypothesis that sera from patients with preeclampsia could function as a "blueprint" of causative factors, we describe a serum-based pregnancy-specific mouse model that closely mirrors the human condition as well as an in vitro predictive assay. We show that a single administration of human preeclampsia serum in pregnant IL-10-/- mice induced the full spectrum of preeclampsia-like symptoms, caused hypoxic injury in uteroplacental tissues, and elevated soluble fms-like tyrosine kinase 1 and soluble endoglin, markers thought to be related to the disease. The same serum sample(s) induced a partial preeclampsia phenotype in wild-type mice. Importantly, preeclampsia serum disrupted cross talk between trophoblasts and endothelial cells in an in vitro model of endovascular activity. Disruption of endovascular activity could be documented in serum samples as early as 12 to 14 weeks of gestation from patients who subsequently developed preeclampsia. These results indicate that preeclampsia patient sera can be used to understand the pregnancy-specific disease pathology in mice and can predict the disorder.
Satyan Kalkunte; Roland Boij; Wendy Norris; Jennifer Friedman; Zhongbin Lai; Jonathan Kurtis; Kee-Hak Lim; James F Padbury; Leif Matthiesen; Surendra Sharma
Related Documents :
10926889 - Quantification and characterization of pregnancy-associated complexes of angiotensinoge...
17437959 - First trimester maternal serum ischaemia-modified albumin: a marker of hypoxia-ischaemi...
16398779 - A longitudinal study of serum adiponectin during normal pregnancy.
17218369 - Serum müllerian-inhibiting substance in down's syndrome pregnancies.
2505949 - Low-normal concentrations of free thyroxin in serum in late pregnancy: physiological fa...
6193519 - Direct evidence for interaction between human erythroid progenitor cells and a hemoglob...
16643719 - Fertility and pregnancy outcomes following hysteroscopic septum division.
19864739 - Small intestinal obstruction in pregnancy and puerperium.
24715419 - Demographic and experiential correlates of public attitudes towards cell-free fetal dna...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2010-10-01
Journal Detail:
Title:  The American journal of pathology     Volume:  177     ISSN:  1525-2191     ISO Abbreviation:  Am. J. Pathol.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-04     Completed Date:  2011-03-21     Revised Date:  2013-07-03    
Medline Journal Info:
Nlm Unique ID:  0370502     Medline TA:  Am J Pathol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2387-98     Citation Subset:  AIM; IM    
Department of Pediatrics, Women and Infants Hospital-Warren Alpert Medical School, Lifespan Center for International Health Research, Brown University, 101 Dudley St, Providence, RI 02905, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biological Assay / methods*
Blood Pressure
Disease Models, Animal*
Gestational Age
Interleukin-10 / blood,  genetics,  immunology
Kidney / pathology
Mice, Knockout
Pre-Eclampsia / blood*,  diagnosis*,  immunology
Pregnancy / blood*,  immunology
Vascular Endothelial Growth Factor Receptor-1 / blood
Grant Support
Reg. No./Substance:
130068-27-8/Interleukin-10; EC protein, mouse; EC Endothelial Growth Factor Receptor-1

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Host defense mechanisms in secondary syphilitic lesions: a role for IFN-gamma-/IL-17-producing CD8+ ...
Next Document:  Matrix metalloproteinases and angiogenic factors: predictors of survival after radical prostatectomy...